Telemus Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $703K | Buy |
800
+1
| +0.1% | +$878 | 0.06% | 196 |
|
|
2023
Q3 | $658K | Sell |
799
-3
| -0.4% | -$2.47K | 0.06% | 192 |
|
|
2023
Q2 | $576K | Buy |
802
+221
| +38% | +$159K | 0.05% | 209 |
|
|
2023
Q1 | $477K | Sell |
581
-21
| -3% | -$17.3K | 0.04% | 221 |
|
|
2022
Q4 | $444K | Buy |
602
+29
| +5% | +$21.4K | 0.04% | 234 |
|
|
2022
Q3 | $395K | Hold |
573
| – | – | 0.04% | 224 |
|
|
2022
Q2 | $339K | Buy |
573
+202
| +54% | +$120K | 0.03% | 269 |
|
|
2022
Q1 | $259K | Buy |
371
+6
| +2% | +$4.19K | 0.02% | 298 |
|
|
2021
Q4 | $231K | Sell |
365
-2
| -0.5% | -$1.27K | 0.02% | 339 |
|
|
2021
Q3 | $222K | Sell |
367
-1,213
| -77% | -$734K | 0.02% | 319 |
|
|
2021
Q2 | $882K | Buy |
1,580
+150
| +10% | +$83.7K | 0.06% | 184 |
|
|
2021
Q1 | $693K | Buy |
1,430
+570
| +66% | +$276K | 0.05% | 241 |
|
|
2020
Q4 | $415K | Sell |
860
-707
| -45% | -$341K | 0.03% | 279 |
|
|
2020
Q3 | $940K | Buy |
1,567
+995
| +174% | +$597K | 0.07% | 202 |
|
|
2020
Q2 | $355K | Hold |
572
| – | – | 0.03% | 319 |
|
|
2020
Q1 | $351K | Buy |
+572
| New | +$351K | 0.03% | 293 |
|
|
2018
Q1 | – | Sell |
-40
| Closed | -$15K | – | 520 |
|
|
2017
Q4 | $15K | Sell |
40
-4,004
| -99% | -$1.5M | ﹤0.01% | 487 |
|
|
2017
Q3 | $1.81M | Hold |
4,044
| – | – | 0.21% | 88 |
|
|
2017
Q2 | $1.99M | Buy |
+4,044
| New | +$1.99M | 0.2% | 85 |
|